Patient Resources

1. Home
2. Patient Resources
3. Health Videos

Get Healthy!

Health News Videos

Experimental Drug Shows Promise in Slowing Disability from Multiple Sclerosis

• April 9, 2025
• HealthDayTV HealthDay Reporter

Results of a phase 3 clinical trial show an experimental drug called tolebrutinib can delay disability in patients with non-relapsing secondary progressive multiple sclerosis.

Multiple SclerosisBrain

Health News is provided as a service to Miller Pharmacy site users by HealthDay. Miller Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Copyright © 2025 HealthDay All Rights Reserved.

Share

---

Tags

Multiple SclerosisBrain